Additionally, it exhibited the ability to reduce the cell surface expression of CD133 by 50%, indicating its potential to effectively control tumor growth by targeting both the central tumor mass and the proliferation of cancer stem cells (CSCs) [202]. Here, PROM1 is linked to neoplasm.